Cambridge, UK-based personalised medicine research tool firm Horizon Discovery has appointed Richard Vellacott as chief financial officer.
He was most recently vice president, finance at hi-tech company CSR, but joins Horizon with over 15 years' experience in working with life science companies.
During this time Vellacott served as a director in Deloitte's life sciences practice, where he specialised in capital market transactions including IPOs, M&A and fundraising on both the UK and the US markets.
Horizon's CEO Dr Darrin Disley said: “I'm delighted to welcome Richard to Horizon. As the company continues to expand, it is essential that we maintain a highly experienced executive team with the skills to deliver our growth objectives. Richard's background is an ideal fit and I very much look forward to working with him.”